Document Detail


Characterization and treatment of resistant hypertension.
MedLine Citation:
PMID:  19863864     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Resistant hypertension is a common medical problem. It carries a significantly increased risk of end-organ damage and cardiovascular events compared with more easily controlled hypertension. Resistant hypertension is most often related to isolated systolic hypertension and is characterized by aldosterone excess and increased intravascular volume. Its diagnosis requires the exclusion of pseudoresistance. The etiology of resistant hypertension is almost always multifactorial. Common reversible contributing factors need to be identified and addressed. Secondary causes of hypertension, such as primary aldosteronism, parenchymal and vascular kidney disease, and obstructive sleep apnea, require investigation and effective treatment if present. Therapy for resistant hypertension should be based on use of rational drug class combinations at optimal doses, with particular attention to adequate diuretic use. The addition of an aldosterone antagonist may further improve blood pressure control.
Authors:
Roberto Pisoni; Mustafa I Ahmed; David A Calhoun
Related Documents :
9854594 - Essential hypertension: first reason for persistent hypertension after unilateral adren...
7662224 - Spectral characteristics of heart rate and blood pressure variability in primary aldost...
6375284 - Effects of verapamil in hypertensive patients.
2354554 - Lack of pressor response to intracerebroventricular infusion of aldosterone in sheep.
1534384 - Effect of saline loading on anp in the cerebrospinal fluid of rats.
21785704 - Management of hypertension among patients with coronary heart disease.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current cardiology reports     Volume:  11     ISSN:  1534-3170     ISO Abbreviation:  Curr Cardiol Rep     Publication Date:  2009 Nov 
Date Detail:
Created Date:  2009-10-29     Completed Date:  2010-03-04     Revised Date:  2014-09-24    
Medline Journal Info:
Nlm Unique ID:  100888969     Medline TA:  Curr Cardiol Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  407-13     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenal Gland Neoplasms / complications
Antihypertensive Agents / therapeutic use*
Blood Pressure
Drug Resistance
Humans
Hyperaldosteronism / complications
Hypertension / drug therapy*,  epidemiology,  etiology
Kidney Failure, Chronic / complications
Life Style
Obesity / complications
Pheochromocytoma / complications
Pituitary ACTH Hypersecretion / complications
Prevalence
Prognosis
Renal Artery Obstruction / complications
Risk Factors
Sleep Apnea, Obstructive / complications
Treatment Failure
United States / epidemiology
Grant Support
ID/Acronym/Agency:
T32 HL007457/HL/NHLBI NIH HHS; T32 HL007457-29/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Antihypertensive Agents
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Treatment of erectile dysfunction following spinal cord injury.
Next Document:  Role of ambulatory and home blood pressure recording in clinical practice.